최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0613621 (2006-12-20) |
등록번호 | US-8870762 (2014-10-28) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 0 인용 특허 : 459 |
A system for remotely monitoring an individual. The system includes a server system for generating a script program from a set of queries. The script program is executable by a remote apparatus that displays information and/or a set of queries to the individual through a user interface. Responses to
A system for remotely monitoring an individual. The system includes a server system for generating a script program from a set of queries. The script program is executable by a remote apparatus that displays information and/or a set of queries to the individual through a user interface. Responses to the queries that are entered through the user interface together with individual identification information are sent from the remote apparatus to the server system across a communication network. The server system also includes an automated answering service for providing a series of questions from a stored set of questions for an individual at the remote apparatus to respond to, storing responses to each provided question in the series of questions and providing a service based on the individual's response to the questions.
1. A method of monitoring a clinical trial, comprising: A) selecting a program from a number of computer programs stored on a server, wherein said program contains one or more queries and one or more corresponding response choices related to efficacy, side effects and quality of life impact of one o
1. A method of monitoring a clinical trial, comprising: A) selecting a program from a number of computer programs stored on a server, wherein said program contains one or more queries and one or more corresponding response choices related to efficacy, side effects and quality of life impact of one or more drugs;B) transmitting the program from said server to a remotely situated apparatus through at least one communication network during a first communication link, wherein the remotely situated apparatus is assigned to a participant of said clinical trial and the program causes the apparatus to present the one or more queries and one or more corresponding response choices to the participant and collect responses, including at least one of the corresponding response choices, from the participant while the remotely situated apparatus is not in communication with said server;C) receiving the responses from the remotely situated apparatus through the at least one communication network during a second communication link and storing the responses in the server, wherein the program causes the remotely situated apparatus to automatically establish the second communication link with the server at a prescribed time and transmit (i) the responses collected from the participant, (ii) a program identification code, and (iii) an identification code associated with the participant; andD) generating a report about said clinical trial based upon the responses, wherein said responses are collected in response to the queries related to the efficacy, side effects and quality of life impact of the one or more drugs with respect to said participant during a clinical development or post marketing surveillance period. 2. The method according to claim 1, further comprising the step of measuring a physiological condition of the participant in order to assess the efficacy, side effects and quality of life impact of said one or more drugs with respect to said participant. 3. The method according to claim 2, wherein said physiological condition comprises a blood oxygen level. 4. The method according to claim 2, wherein said physiological condition comprises a blood glucose level. 5. The method according to claim 2, wherein said physiological condition comprises a blood pressure. 6. The method according to claim 2, wherein said physiological condition comprises a respiratory flow rate. 7. The method according to claim 1, wherein said participant is managing a chronic disease or condition. 8. The method according to claim 7, wherein said chronic disease comprises chronic obstructive pulmonary disease (COPD). 9. The method according to claim 1, further comprising the steps of: entering queries related to said clinical trial and corresponding response choices into the server;generating one or more programs in the server using the queries and the response choices; andstoring the one or more programs on the server. 10. The method according to claim 1, wherein said program is customized for said participant. 11. The method according to claim 10, wherein said program is customized to the participant by merging personal data with a generic program. 12. The method according to claim 1, further comprising: assigning a unique identification code associated with the participant to the remotely situated apparatus. 13. The method according to claim 1, further comprising: notifying the participant when one or more unanswered queries remain in the remotely situated apparatus through activation of a visual indicator controlled by said program. 14. The method according to claim 1, wherein: the program includes a connection routine configured to cause the remotely situated apparatus to prompt the participant to connect the remotely situated apparatus to the at least one communication network. 15. The method according to claim 14, wherein: the program includes a connection routine configured to automatically cause the remotely situated apparatus to establish the second communication link with the server at a prescribed time, transmit the responses collected from the participant, transmit the program identification code, and transmit the identification code associated with the participant. 16. The method according to claim 15, further comprising: transmitting a new program to the remotely situated apparatus through the at least one communication network after receiving the responses collected from the participant, the program identification code, and the identification code associated with the participant; andinstructing the remotely situated apparatus to disconnect the second communication link. 17. The method according to claim 1, further comprising: presenting said remotely situated apparatus as an image of a stand-alone remote apparatus on a display of a personal computer of the participant, wherein the individual interacts with the displayed image of the stand-alone remote apparatus by operating one or more user interfaces of the personal computer to select displayed responses. 18. A system for remotely monitoring a pharmaceutical trial, comprising: a server that communicates through at least one communication network;at least one remotely situated hand-held portable apparatus provided to at least one participant of said pharmaceutical trial, wherein said at least one remotely situated apparatus is configured to automatically establish a communication link with said server through said at least one communication network;a user interface that communicates with the server, said user interface adapted for (i) entering, authoring, selecting, or any combination thereof, a set of queries to be answered by the participant and (ii) entering, authoring, selecting, or any combination thereof, corresponding response choices for each of the queries, wherein said queries and said corresponding response choices relate to said pharmaceutical trial;a program generator configured to generate a program to be executed by the remotely situated apparatus, wherein the program causes the apparatus to (i) present the queries and the corresponding response choices to the participant and collect responses from the participant, including at least one of the corresponding response choices, after a first communication link between the server and the remotely situated apparatus is terminated and (ii) send the collected responses, a program identification code, and an identification code associated with the participant to the server after autonomously establishing a second communication link between the server and the remotely situated apparatus; andone or more databases accessible by the server, said one or more databases storing the program, the responses received from the remotely situated apparatus and a list of pharmaceutical trial criteria, wherein the pharmaceutical criteria are assessed based upon the responses received. 19. The system according to claim 18, further comprising a monitoring device remotely situated from the server, the monitoring device configured to measure a physiological condition of the participant, wherein measurement of the physiological condition of the participant is used in assessing the pharmaceutical criteria. 20. The system according to claim 19, wherein said physiological condition comprises one or more of a blood oxygen level, a blood glucose level, a blood pressure and a respiratory flow rate. 21. The system according to claim 18, wherein said pharmaceutical trial is directed to collecting data on efficacy, side effects and quality of life impact of one or more drugs on the participant during a clinical development and post marketing surveillance period.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.